Search
for
Sort by
Research 31–60 of 871
- Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis
- Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report
- Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Use of Hydroxychloroquine in Hair Disorders
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Resolution of Discoid Lupus Alopecia With Systemic Hydroxychloroquine and Topical Pimecrolimus Combination Therapy
- Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial
- A randomised, open label comparative study of hydroxychloroquine with betamethasone oral mini pulse in the management of patients with alopecia areata
- 568 Evaluating results of an interferon-γ release assay in patients with autoimmune skin disease on hydroxychloroquine
- A randomised open label comparative study of hydroxychloroquine with betamethasone oral minipulse in the management of patients with alopecia areata.
- Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
- Frontal Fibrosing Alopecia Successfully Treated with Intralesional Betamethasone and Oral Hydroxychloroquine: A Case Report
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- BH06: Clinical trial of combination therapy with oral hydroxychloroquine and topical tacrolimus versus oral finasteride and topical tacrolimus in frontal fibrosing alopecia
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Frontal fibrosing alopecia: a clinical review of 36 patients
- Frontal fibrosing alopecia: clinical presentations and prognosis
- Lupus erythematosus: systemic and cutaneous manifestations
- Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
- Primary cicatricial alopecia
- Lichen planopilaris
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Alopecia: evaluation and treatment
- Cutaneous lupus erythematosus
- Pediatric Systemic Lupus Erythematosus: More Than a Positive Antinuclear Antibody